Houston John G
SEC CIK 1753537 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| ARVN | ARVINAS, INC. | Pres, CEO, Dir | 1.12M | — | $9.81M | 15 | 2021-08-02 | 2026-02-27 |
Most active insiders at ARVN, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Houston John G | Dir | — | $466.2K |
| 2 | Morrison Briggs | Dir | $268.0K | — |
| 3 | Berkowitz Noah | Chief Medical Off | — | $249.4K |
| 4 | Teel Randy | Pres, CEO, Dir | — | $226.5K |
| 5 | Saik Andrew | CFO | — | $218.2K |
| 6 | Cacace Angela M | CSO | — | $214.0K |
| 7 | Loomis David K | VP, CAO | — | $46.9K |
| 8 | Kennedy Edward Moore Jr. | Dir | — | — |
| 9 | Smaldone Alsup Laurie | Dir | — | — |
| 10 | Bain Linda | Dir | — | — |
Transactions 15
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2026-03-02 | 2026-02-27 | ARVN | ARVINAS, INC. | Houston John G | Dir | S - Sale | $13.21 | -35.3K | 1.12M | -3% | -$466.2K |
| M | 2025-02-25 | 2025-02-24 | ARVN | ARVINAS, INC. | Houston John G | Pres, CEO, Dir | S - Sale | $16.72 | -31.3K | 1.16M | -3% | -$523.9K |
| D | 2025-02-18 | 2025-02-13 | ARVN | ARVINAS, INC. | Houston John G | Pres, CEO, Dir | A - Grant | $0.00 | +152.0K | 1.19M | +15% | $0 |
| D | 2024-02-27 | 2024-02-23 | ARVN | ARVINAS, INC. | Houston John G | Pres, CEO, Dir | A - Grant | $0.00 | +124.5K | 1.04M | +14% | $0 |
| D | 2024-02-27 | 2024-02-23 | ARVN | ARVINAS, INC. | Houston John G | Pres, CEO, Dir | S - Sale | $47.05 | -5,196 | 1.04M | -0.5% | -$244.5K |
| D | 2023-03-03 | 2023-03-01 | ARVN | ARVINAS, INC. | Houston John G | Pres, CEO, Dir | M - OptEx | — | +17.5K | 923.3K | +2% | — |
| D | 2023-03-03 | 2023-03-01 | ARVN | ARVINAS, INC. | Houston John G | Pres, CEO, Dir | S - Sale+OE | $29.53 | -5,878 | 917.4K | -0.6% | -$173.6K |
| D | 2023-02-24 | 2023-02-22 | ARVN | ARVINAS, INC. | Houston John G | Pres, CEO, Dir | A - Grant | $0.00 | +62.0K | 905.8K | +7% | $0 |
| D | 2022-03-04 | 2022-03-04 | ARVN | ARVINAS, INC. | Houston John G | Pres, CEO, Dir | S - Sale+OE | $63.94 | -6,024 | 843.8K | -0.7% | -$385.2K |
| D | 2022-03-04 | 2022-03-04 | ARVN | ARVINAS, INC. | Houston John G | Pres, CEO, Dir | M - OptEx | — | +17.5K | 849.8K | +2% | — |
| DM | 2021-11-03 | 2021-11-01 | ARVN | ARVINAS, INC. | Houston John G | Pres, CEO, Dir | S - Sale+OE | $88.14 | -40.0K | 847.9K | -5% | -$3.53M |
| D | 2021-11-03 | 2021-11-01 | ARVN | ARVINAS, INC. | Houston John G | Pres, CEO, Dir | M - OptEx | $16.00 | +40.0K | 872.3K | +5% | +$640.0K |
| DM | 2021-09-07 | 2021-09-02 | ARVN | ARVINAS, INC. | Houston John G | Pres, CEO, Dir | M - OptEx | $16.00 | +4,690 | 832.3K | +0.6% | +$75.0K |
| D | 2021-08-04 | 2021-08-02 | ARVN | ARVINAS, INC. | Houston John G | Pres, CEO, Dir | M - OptEx | $16.00 | +45.9K | 873.6K | +6% | +$734.8K |
| DM | 2021-08-04 | 2021-08-02 | ARVN | ARVINAS, INC. | Houston John G | Pres, CEO, Dir | S - Sale+OE | $97.83 | -45.9K | 841.4K | -5% | -$4.49M |
Purchase Sale Sale after option exercise All abbreviations